Percent Free Prostate-Specific Antigen Measurement

Known as: Free Prostate-Specific Antigen, Percent Free Prostate-Specific Antigen, free PSA 
The amount of the protein prostate-specific antigen (PSA) in the blood that is not attached to other proteins. It is compared with the amount of PSA… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml…
BACKGROUND Total prostate-specific antigen (tPSA), ratio of free PSA (fPSA) to tPSA (%fPSA), and PSA density (PSAD) testing have… (More)
  • table 1
  • table 2
  • table 2
  • figure 1
  • table 3
Is this relevant?
2004
2004
Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?
BACKGROUND The combined use of free and total prostate-specific antigen (PSA) in early detection of prostate cancer has been… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Femtomolar detection of prostate-specific antigen: an immunoassay based on surface-enhanced Raman scattering and immunogold labels.
A novel reagent for low-level detection in immunoadsorbent assays is described. The reagent consists of gold nanoparticles… (More)
Is this relevant?
2001
2001
Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients.
INTRODUCTION The aim of our study was to evaluate the clinical usefulness of percent free prostate-specific antigen (PSA) [ratio… (More)
Is this relevant?
2000
2000
Serum total and free prostate-specific antigen for breast cancer diagnosis in women.
Prostate-specific antigen (PSA) is a serine protease expressed at high levels in prostate epithelium, and elevated PSA in serum… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
CONTEXT The percentage of free prostate-specific antigen (PSA) in serum has been shown to enhance the specificity of PSA testing… (More)
  • table 1
  • table 2
  • figure 2
  • figure 1
  • table 5
Is this relevant?
1997
1997
Effect of ejaculation on serum total and free prostate-specific antigen concentrations.
OBJECTIVES Measurement of total serum prostate-specific antigen (PSA) is widely used as an aid to early detection of prostate… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age.
OBJECTIVES To determine whether the use of the free-to-total PSA ratio (percent free PSA) could increase the specificity of PSA… (More)
Is this relevant?
1996
1996
Analytical performance and clinical validity of two free prostate-specific antigen assays compared.
We compared two recently introduced commercial assays (CanAg and Immulite) for measuring free prostate-specific antigen (f-PSA… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.
OBJECTIVE To evaluate measurement of percentage of free prostate-specific antigen (PSA) in serum to improve the specificity of… (More)
Is this relevant?